Use of anti-FAM19A5 antibody for cancer treatment

The present invention specifically binds to FAM19A5 to promote vascular normalization and, for example, to promote vascular normalization, thereby antagonists (eg antibodies or antigen-binding portions thereof) for treating a disease (eg cancer) in a subject. ) For pharmaceutical use.